BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Anticancer prodrugs
,
Trichostatin A
,
rs2476601
,
PBX1
,
Coagulation
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vorapaxar
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
No benefit of vorapaxar on walking performance in patients with intermittent claudication.
Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events - A Review on Vorapaxar.
Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD …
Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Diseas…
Vorapaxar in the treatment of cardiovascular diseases.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Vorapaxar in the Human Endotoxemia Model
Influence of Vorapaxar on Thrombin Generation and Coagulability
Vorapaxar and Lower Extremity Bypass Grafts
Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access
Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ